FILED PURSUANT TO RULE 424(B)(3)
REGISTRATION NO.: 333-263732
NXP B.V.
NXP FUNDING LLC
NXP USA, Inc.
Offers to Exchange
Up to $500,000,000 2.700% Senior Notes due 2025 (the “Outstanding 2025 Notes”) for up to $500,000,000 2.700% Senior Notes due 2025 (the “New 2025 Notes”) that have been registered under the Securities Act of 1933, as amended (the “Securities Act”)
Up to $750,000,000 3.875% Senior Notes due 2026 (the “Outstanding 2026 Notes”) for up to $750,000,000 3.875% Senior Notes due 2026 (the “New 2026 Notes”) that have been registered under the Securities Act
Up to $500,000,000 3.150% Senior Notes due 2027 (the “Outstanding 2027 Notes”) for up to $500,000,000 3.150% Senior Notes due 2027 (the “New 2027 Notes”) that have been registered under the Securities Act
Up to $1,000,000,000 4.300% Senior Notes due 2029 (the “Outstanding 2029 Notes”) for up to $1,000,000,000 4.300% Senior Notes due 2029 (the “New 2029 Notes”) that have been registered under the Securities Act
Up to $1,000,000,000 3.400% Senior Notes due 2030 (the “Outstanding 2030 Notes”) for up to $1,000,000,000 3.400% Senior Notes due 2030 (the “New 2030 Notes”) that have been registered under the Securities Act
Up to $1,000,000,000 2.500% Senior Notes due 2031 (the “Outstanding 2031 Notes”) for up to $1,000,000,000 2.500% Senior Notes due 2031 (the “New 2031 Notes”) that have been registered under the Securities Act
Up to $1,000,000,000 2.650% Senior Notes due 2032 (the “Outstanding 2032 Notes”) for up to $1,000,000,000, 2.650% Senior Notes due 2032 (the “New 2032 Notes”) that have been registered under the Securities Act
Up to $1,000,000,000 3.250% Senior Notes due 2041 (the “Outstanding 2041 Notes”) for up to $1,000,000,000 3.250% Senior Notes due 2041 (the “New 2041 Notes”) that have been registered under the Securities Act
Up to $500,000,000 3.125% Senior Notes due 2042 (the “Outstanding 2042 Notes”) for up to $500,000,000 3.125% Senior Notes due 2042 (the “New 2042 Notes”) that have been registered under the Securities Act
Up to $500,000,000 3.250% Senior Notes due 2051 (the “Outstanding 2051 Notes” and together with the Outstanding 2025 Notes, the Outstanding 2026 Notes, the Outstanding 2027 Notes, the Outstanding 2029 Notes, the Outstanding 2030 Notes, the Outstanding 2031 Notes, the Outstanding 2032 Notes, the Outstanding 2041 Notes, and the Outstanding 2042 Notes, the “Outstanding Notes”) for up to $500,000,000 3.250% Senior Notes due 2051 (the “New 2051 Notes” and together with the New 2025 Notes, the New 2026 Notes, the New 2027 Notes, the New 2029 Notes, the New 2030 Notes, the New 2031 Notes, the New 2032 Notes, the New 2041 Notes and the New 2042 Notes, the “New Notes”) that have been registered under the Securities Act
We are offering to exchange up to $500,000,000 aggregate principal amount of our New 2025 Notes for a like aggregate principal amount of our Outstanding 2025 Notes, up to $750,000,000 aggregate principal amount of our New 2026 Notes for a like aggregate principal amount of our Outstanding 2026 Notes, up to $500,000,000 aggregate principal amount of our New 2027 Notes for a like aggregate principal amount of our Outstanding 2027 Notes, up to $1,000,000,000 aggregate principal amount of our New 2029 Notes for a like aggregate principal amount of our Outstanding 2029 Notes, up to $1,000,000,000 aggregate principal amount of our New 2030 Notes for a like aggregate principal amount of our Outstanding 2030 Notes, up to $1,000,000,000 aggregate principal amount of our New 2031 Notes for a like aggregate principal amount of our Outstanding 2031 Notes, up to $1,000,000,000 aggregate principal amount of our New 2032 Notes for a like aggregate principal amount of our Outstanding 2032 Notes, up to $1,000,000,000 aggregate principal amount of our New 2041 Notes for a like aggregate principal amount of our Outstanding 2041 Notes, up to $500,000,000 aggregate principal amount of our New 2042 Notes for a like aggregate principal amount of our Outstanding 2042 Notes, and up to $500,000,000 aggregate principal amount of our New 2051 Notes for a like aggregate principal amount of our Outstanding 2051 Notes in a transaction registered under the Securities Act (each, an “Exchange Offer” and collectively, the “Exchange Offers”).
The Exchange Offers will expire at 5:00 p.m., New York, New York time, on May 12, 2022 (the “Expiration Date”), unless we extend the Exchange Offers with respect to any or all series of Outstanding Notes in our sole and absolute discretion. We will announce any extension by press release or other permitted means no later than 9:00 a.m. on the business day after the expiration of the Exchange Offers. You may withdraw any Outstanding Notes of any series tendered until the expiration of the applicable Exchange Offer.
Terms of the Exchange Offers:
| • | | We will exchange the applicable series of New Notes for Outstanding Notes of the applicable series that are validly tendered and not withdrawn prior to the expiration or termination of the Exchange Offers with respect to such series. |
| • | | You may validly withdraw tenders of Outstanding Notes of a series at any time prior to the expiration or termination of the Exchange Offers with respect to such series. |
| • | | The form and terms of the New Notes are substantially identical to the form and terms of the applicable Outstanding Notes, except that (i) the New Notes are registered under the Securities Act, (ii) the transfer restrictions and registration rights applicable to the Outstanding Notes do not apply to the New Notes and (iii) the New Notes will not have the right to earn additional interest under certain circumstances related to our registration obligations. |
| • | | We believe that the exchange of Outstanding Notes for New Notes will not be a taxable event for U.S. federal income tax purposes. |
| • | | We will not receive any proceeds from the Exchange Offers. |
| • | | We issued the Outstanding Notes in transactions not requiring registration under the Securities Act, and as a result, their transfer is restricted. We are making the Exchange Offers to satisfy your registration rights, as a holder of the Outstanding Notes. |
For a discussion of factors you should consider in determining whether to tender your Outstanding Notes in connection with the Exchange Offers, see the information under “Risk Factors” beginning on page 13 of this prospectus and in our Annual Report on Form 10-K, which is incorporated by reference into this prospectus.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities, or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
The date of this prospectus is April 14, 2022.